Urist Marshall

CIK 00018381391 companyNEW YORK, NY

SEC Profile

Transactions

Companies

Filings

CIK

0001838139

Recent Transactions

33 trades

Sale
Royalty Pharma plc$RPRX
Class A Ordinary Shares
2026-01-16$39.52/sh−20,000→ 40,000 total
Sale
Royalty Pharma plc$RPRX
Class A Ordinary Shares
2026-01-09$40.78/sh−20,000→ 60,000 total
Sale
Royalty Pharma plc$RPRX
Class A Ordinary Shares
2026-01-02$38.48/sh−20,000→ 80,000 total
Sale
Royalty Pharma plc$RPRX
Class A Ordinary Shares
2025-12-19$38.38/sh−20,000→ 120,000 total
Sale
Royalty Pharma plc$RPRX
Class A Ordinary Shares
2025-12-16$38.32/sh−20,000→ 140,000 total
Sale
Royalty Pharma plc$RPRX
Class A Ordinary Shares
2025-12-05$39.15/sh−23,334→ 160,000 total
Sale
Royalty Pharma plc$RPRX
Class A Ordinary Shares
2025-12-05$39.15/sh−18,242→ 7,398 total
Sale
Royalty Pharma plc$RPRX
Class A Ordinary Shares
2025-12-01$39.93/sh−23,333→ 183,334 total
Sale
Royalty Pharma plc$RPRX
Class A Ordinary Shares
2025-12-01$39.90/sh−18,242→ 25,640 total
Conversion
Royalty Pharma plc$RPRX
LP interests in RPI US Partners 2019, LP
2025-11-07−16,000→ 247,412 total
Conversion
Royalty Pharma plc$RPRX
Class A Ordinary Shares
2025-11-07+160,000→ 206,667 total
Award
Royalty Pharma plc$RPRX
Class A Ordinary Shares
2025-11-05+4,626→ 43,882 total
Gift
Royalty Pharma plc$RPRX
LP interests in RPI US Partners 2019, LP
2025-08-08−3,000→ 263,412 total
Award
Royalty Pharma plc$RPRX
Class A Ordinary Shares
2025-08-06+2,772→ 39,256 total
Award
Royalty Pharma plc$RPRX
Class E Ordinary Shares
2025-05-16+1,356,528→ 1,356,528 total
Award
Royalty Pharma plc$RPRX
Class A Ordinary Shares
2025-05-08+36,484→ 83,151 total
Gift
Royalty Pharma plc$RPRX
LP interests in RPI US Partners 2019, LP
2024-08-12−2,182→ 126,412 total
Sale
Royalty Pharma plc$RPRX
Class A Ordinary Shares
2023-02-22$37.30/sh−23,333→ 46,667 total
Conversion
Royalty Pharma plc$RPRX
LP interests in RPI US Partners 2019, LP
2023-02-17−7,000→ 128,594 total
Conversion
Royalty Pharma plc$RPRX
Class A Ordinary Shares
2023-02-17+70,000→ 70,000 total
Sale
Royalty Pharma plc$RPRX
Class A Ordinary Shares
2022-07-26$43.20/sh−19,734→ 0 total
Sale
Royalty Pharma plc$RPRX
Class A Ordinary Shares
2022-07-25$43.05/sh−3,600→ 19,734 total
Sale
Royalty Pharma plc$RPRX
Class A Ordinary Shares
2022-06-24$43.19/sh−23,333→ 23,334 total
Sale
Royalty Pharma plc$RPRX
Class A Ordinary Shares
2022-05-16$39.85/sh−23,333→ 46,667 total
Conversion
Royalty Pharma plc$RPRX
LP interests in RPI US Partners 2019, LP
2022-05-11−7,000→ 205,594 total
Conversion
Royalty Pharma plc$RPRX
Class A Ordinary Shares
2022-05-11+70,000→ 70,000 total
Sale
Royalty Pharma plc$RPRX
Class A Ordinary Shares
2021-06-07$47.02/sh−16,568→ 0 total
Sale
Royalty Pharma plc$RPRX
Class A Ordinary Shares
2021-06-04$45.13/sh−16,566→ 16,568 total
Sale
Royalty Pharma plc$RPRX
Class A Ordinary Shares
2021-06-02$41.52/sh−14,566→ 33,134 total
Sale
Royalty Pharma plc$RPRX
Class A Ordinary Shares
2021-05-21$41.00/sh−100→ 47,700 total
Sale
Royalty Pharma plc$RPRX
Class A Ordinary Shares
2021-05-20$41.08/sh−1,900→ 47,800 total
Conversion
Royalty Pharma plc$RPRX
Class A Ordinary Shares
2021-05-07+49,700→ 49,700 total
Conversion
Royalty Pharma plc$RPRX
LP interests in RPI US Partners 2019, LP
2021-05-07−4,970→ 142,594 total

Companies

Royalty Pharma plc
EVP, Research & Investments
$RPRX

Recent Filings

Address

C/O ROYALTY PHARMA PLC 110 EAST 59TH STREET

NEW YORK, NY, 10022

View on SEC.gov